Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.
about
Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development and validation of ...... on to a pharmacokinetic study.
@ast
Development and validation of ...... on to a pharmacokinetic study.
@en
Development and validation of ...... on to a pharmacokinetic study.
@nl
type
label
Development and validation of ...... on to a pharmacokinetic study.
@ast
Development and validation of ...... on to a pharmacokinetic study.
@en
Development and validation of ...... on to a pharmacokinetic study.
@nl
prefLabel
Development and validation of ...... on to a pharmacokinetic study.
@ast
Development and validation of ...... on to a pharmacokinetic study.
@en
Development and validation of ...... on to a pharmacokinetic study.
@nl
P2093
P2860
P356
P1476
Development and validation of ...... on to a pharmacokinetic study.
@en
P2093
Avinash Kumar
Mohd Zainuddin
Purushottam Dewang
Raghava Reddy Kethiri
Ramesh Mullangi
Sandip Gurav
Sriram Rajagopal
Vijay Kumar S
P2860
P304
P356
10.1002/BMC.2964
P577
2013-06-21T00:00:00Z